William Starling

Partner

About

Experienced Chief Executive Officer with a demonstrated history of working in the medical device industry. Skilled in Medical Devices, Sales, Venture Capital, Sales Management, and Management. Strong business development professional with a Master of Business Administration (MBA) focused in Marketing Management, Finance from University of Southern California - Marshall School of Business.

Country

United States

City

Portola Valley

Industry

Medical Device

Skill

Strategic Planning, Management, New Business Development, Sales, Leadership, Customer Service, Marketing Strategy, Project Management, Sales Management, Product Development, Business Development, Start-ups, Venture Capital, Medical Devices, FDA, Cross-functional Team Leadership, Commercialization, Product Management

Experience

Partner

Cardiovascular Masters Consortium

2024-1 - Present · 2 yrs 9 mos

Research Triangle Park, NC

See: www.cardiovascularmasters.com We are a unique assembly of renowned cardiologists and medical device entrepreneurs, each a titan in their field, committed to advancing medical device innovation and enhancing patient care through our consensus-driven approach. Choosing the Cardiovascular Masters Consortium means partnering with the zenith of cardiac medical thought leadership. Our unique consensus approach leverages collective wisdom to accelerate your product’s journey, mitigate development risks, and enhance quality. Discover how our strategic partnership can elevate your innovations and maximize your impact on patient outcomes.

Chief Beverage Officer

The Covid Book Club

2019-1 - Present · 7 yrs 9 mos

Zotts

CEO and Co-founder

Synecor, LLC

2000-9 - 2024-10 · 24 yrs 2 mos

Research Triangle Park, NC

see: www.synecor.com

Managing Partner and Co-founder

Synergy Life Science Partners

2006-12 - 2020-12 · 14 yrs 1 mo

San Francisco, CA

$143 M Early Stage Medical Device Venture Capital Fund See: www.synergylsp.com

Co-founder, Chairman of the Board, President and CEO

Cardiac Pathways Corporation

1992-1 - 2001-8 · 9 yrs 8 mos

Sunnyvale, CA

First company approved by the FDA for a Ventricular Tachyarrhythmia ablation indication, in 1999. Startup CEO from inception in 1992 through May 1999, including IPO (NASD:CPWY) in June 1996; Chairman of the Board through 2001 when acquired by Boston Scientific Corporation.

Co-Founder, VP and BOD member

Ventritex, Inc.

1985-7 - 1991-12 · 6 yrs 6 mos

Sunnyvale, CA

Co-founder and member of startup management team that was responsible for developing the first microprocessor controlled tiered therapy implantable defibrillator (ICD) that was implanted in a human (July '89). IPO in 1992 (NASD:VNTX); Acquired by St. Jude Medical in 1997.

Director of Marketing

Advanced Cardiovascular Systems, Inc.

1982-3 - 1985-8 · 3 yrs 6 mos

Mountain View, CA

Responsible for all marketing activities for ACS from startup through purchase by Eli Lilly in May 1984. ACS is now Abbott (Labs) Vascular via the Guidant acquisition in 2006. Guidant/Abbott Vascular also acquired BVS (Absorb Bioresorbable Vascular Scaffold System) from Synecor in 2003/2004.

Technical Sales and Marketing Management

American Edwards Laboratories

1977-6 - 1982-3 · 4 yrs 10 mos

Irvine, CA

Technical sales of American Edwards Laboratories (now Edwards Lifesciences) artificial heart valves and Swan-Ganz thermodilution cardiac output catheters in Wisconsin 1977-1979; Marketing product management of Fogarty vascular catheters and vascular instruments 1979-1982; Fogarty Coronary Angioplasty and Ganz Intracoronary Reperfusion product development and business development 1980-1982.